Antirheumatic Drug Intake Influence on Occurrence of COVID-19 Infection in Ambulatory Patients with Immune-Mediated Inflammatory Diseases: A Cohort Study

ConclusionsNo antirheumatic drug intake was associated with an increased or decreased risk of developing COVID-19 infection in our cohort of patients suffering from immune-mediated inflammatory diseases.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research

Related Links:

The $335.8 million, 182,800-square-foot structure is the first start-to-finish UCSF construction project since the start of the Covid-19 pandemic, with the clinical building opening in 2024.
Source: Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
The CDC is urging parents and guardians to vaccinate children aged 5 to 11 against COVID-19 once the shot is fully approved.WebMD Health News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Infectious Diseases News Source Type: news
At least 59,000 meatpacking workers caught COVID-19 and 269 workers died last year, which is significantly more than previously thought, according to a new US House report released Wednesday.Associated Press
Source: Medscape FamilyMedicine Headlines - Category: Primary Care Tags: Infectious Diseases News Source Type: news
"WHO Technical Advisory Group for Emergency Use Listing (EUL) is an independent advisory group that provides recommendations to WHO on whether a #COVID19 vaccine can be listed for emergency use under the EUL procedure," the WHO tweeted.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
Local health care executives give their take on the Covid-19 pandemic and challenges they've faced.
Source: Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Source Type: news
This study included 1430 retrieved articles with open access mostly. The top five journals in this field were Annals of the Rheumatic Diseases (n = 65), Rheumatology International (n = 51), Clinical Rheumatology (n = 50), Lancet Rheumatology (n = 50), and Frontiers In Immunology (n = 33). Most studies originate from countries with a high incidence of COVID-19 among the general population (the USA—387; Italy—268; UK—184; France—114; Germany—110; India—98 and Spain—96, China—94, Canada—73 Turkey—6...
Source: Rheumatology International - Category: Rheumatology Source Type: research
This study aimed to assess the baseline characteristics and clinical outcomes of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases and identify the risk factors associated with severe COVID-19 pneumonia. This was a retrospective study in a tertiary care center conducted through the period between March 2020 and November 2020 and included all adult patients with rheumatic diseases who tested positive on the COVID-19 polymerase chain reaction (PCR) test. We assessed the patients ’ demographic data, history of rheumatic disease, COVID-19 symptoms and experimental treatment, if any, their disease co...
Source: Rheumatology International - Category: Rheumatology Source Type: research
Conclusion During the first peak of SARS-CoV-2, the number of patients reporting COVID-19 symptoms appeared high and was associated with high levels of anxiety. As only a small number have been swab-tested, this may suggest that larger numbers of untested individuals have had COVID-19 with mild symptoms. Fe atures of inflammatory rheumatic illnesses may mimic COVID-19 symptoms and create diagnostic difficulty (joint pain and fatigue) whilst anxiety may lead to over-reporting of symptoms in the absence of infection. The key symptoms of fever, cough and SOB were less common and may be most reliable.Disclosure M. Lw...
Source: Rheumatology - Category: Rheumatology Source Type: research
Abstract OBJECTIVE: To assess concerns and healthcare-related behaviors of patients with autoimmune rheumatic diseases during the COVID-19 pandemic. METHODS: Adults from the United States with rheumatoid arthritis (RA), psoriatic arthritis (PsA), ankylosing spondylitis (AS), and systemic lupus erythematosus (SLE) from the ArthritisPower Patient-Powered Research Network and CreakyJoints patient community completed surveys. Concerns and behaviors were compared among patients with different autoimmune conditions, disease-modifying anti-rheumatic drug (DMARD) use, and geographic measures of urban status, income, ...
Source: J Rheumatol - Category: Rheumatology Authors: Tags: J Rheumatol Source Type: research
ConclusionsLack of availability of sound scientific knowledge inevitably lead unreliable news to spread over the population, preventing people to disentangle them form reliable information. Even if additional studies are needed to replicate and strengthen our results, these findings represent initial evidence to derive recommendations based on actual data for subjects with autoimmune diseases.
Source: Autoimmunity Highlights - Category: Allergy & Immunology Source Type: research
More News: Arthritis | COVID-19 | Electronic Medical Records (EMR) | France Health | Hydroxychloroquine | Lupus | Opthalmology | Psoriatic Arthritis | Rheumatoid Arthritis | Rheumatology | Study